Reminder: Important Update from the Executive Office of Health and Human Services: New Reporting Requirements for Municipalities Receiving Opioid Abatement Funds

The Executive Office of Health & Human Services (EOHHS) announced that beginning July 1, 2025, all municipalities receiving opioid abatement funds will be required to submit an annual expenditure report. Under this new requirement, every municipality is required to report its spending regardless of the amount of funding received or the year it was allocated. Prior to FY25, only those municipalities that received $35,000 or more were mandated to report. 

According to EOHHS, this new approach establishes straightforward guidelines, which will help ensure consistent reporting across all municipalities. By standardizing the reporting process, EOHHS hopes to create a more effective framework for monitoring the use of these critical resources. 

This year, the Massachusetts Department of Public Health’s Bureau of Substance Addiction Services (BSAS) will oversee the management of the annual expenditure report. The report format has been redesigned to simplify the process for municipalities and provide a precise accounting of how opioid abatement funds are used by capturing expenditures at the line-item level.  

Municipalities opting to redirect all their opioid abatement funds to the statewide Opioid Recovery & Remediation Trust Fund (ORRF) will not be required to submit this report. 

Resources for Filing the FY25 Annual Expenditure Report

Several resources are available to support municipalities in completing their annual expenditure reports and ensuring they can meet the new reporting requirements.  

On August 18, Mosaic and BSAS hosted a webinar to explain the updated reporting process, highlight key changes based on past feedback, and explain how accurate reporting can enhance local fund utilization and transparency in opioid abatement efforts. You can find a recording of the webinar and the slideshow here.

Additional resources, including a guidance document, FAQ, video walkthroughs, and sample reports, can be found here.

The reporting deadline is November 1, 2025. For inquiries, email DPH-MunicipalOpioid-SettlementWork@mass.gov.

The Massachusetts Attorney General’s Office (AGO) has agreed to join settlements with (a) opioid manufacturer Purdue Pharma and its owners, the Sackler family, and (b) opioid manufacturers Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun, and Zydus, as described in an AGO press release.

As with the Commonwealth’s previous opioid settlements, Massachusetts municipalities have the opportunity to participate in these new settlements. Generally, the more Massachusetts municipalities that participate, the more settlement funds will flow to the Commonwealth and its municipalities. If all required municipalities sign on to the agreements, the Commonwealth and its municipalities will receive the maximum amount possible in abatement funds. 

Attorney General Andrea Joy Campbell is hosting a webinar on September 4, 2025 about the opportunity. Attendees will learn about the process to sign on to these settlements, and a municipal representative will discuss how prior settlement funds were used to benefit the community. 

Register here. The link may be shared with individuals or groups who may benefit from attending.

Before the webinar, the AGO asks municipal officials to leave comments on the registration form expressing questions they want addressed.

Questions about the webinar may be directed to AGOCommunityEngagement@mass.gov.

Save the Date: Municipal Matching Grant Webinar

On October 2, 2025, Mosaic is hosting a webinar on the upcoming Municipal Matching Grant. This is the second round of Municipal Matching Grants through Mosaic. The guidelines and application will be released on September 16, 2025, and this session will cover eligibility, timelines, and how to apply. Registration link coming soon! 

Update Your Contact Information

Please take a moment to update your contact information to ensure you receive all the latest updates and information from Mosaic. Accurate and current details allow us to communicate important announcements, program updates (including expenditure reporting), and learning opportunities directly to you.

You can easily update your contact information by clicking here. 

Your participation in keeping your records current is essential for maintaining a strong connection within our community. Thank you for helping us stay in touch!

Questions or Need Support?

Please fill out the form on the Mosaic Municipal TTA Program web page, or email us at munitta@rizema.org. We’re here to help!

About RIZE Massachusetts:

RIZE Massachusetts Foundation (RIZE) is solely dedicated to funding and collaborating on solutions to end the overdose crisis. Guided by those with lived and living experience and unafraid of new ideas, RIZE is building networks, designing programming, and supporting community partners who are using novel approaches to preventing overdose and increasing access to treatment and recovery supports. RIZE makes health equity a programmatic priority by addressing root causes such as racism, systemic barriers to care, and power imbalances. Learn more at www.rizema.org.

About Mosaic:

Mosaic Opioid Recovery Partnership (Mosaic), funded by the MA Department of Public Health, Bureau of Substance Addiction Services and powered by RIZE, is a unique, public-private collaboration designed to fund initiatives that are addressing the opioid overdose crisis in communities and populations that have been historically underserved and have experienced a high rate of opioid-related overdose deaths. Guided by people with lived and living experience, Mosaic is a once-in-a-lifetime opportunity to lift up and bring together the best and most promising ideas to save lives, end stigma, and improve quality of life for people living with substance use disorder. Learn more at mosaic.rizema.org.